Relating to the creation of the Alzheimer's Prevention and Research Institute of Texas.

89th Legislature (2025) Introduced by Judith Zaffirini

Texas proposes creating a dedicated Alzheimer's research and prevention institute to address the state's growing dementia crisis through coordinated research and treatment initiatives.

Referred to Finance

#alzheimer'sdisease(s4186) #alzheimer'sprevention&researchinstituteoftexas(v97kz) #audits&auditors(s4334) #baylorcollegeofmedicine(u0250) #business&commerce--copyright #patents #&trademarks(i0004) #electronicinformationsystems(i0311) #ethics(i0345) #governor(i0375) #historicallyunderutilizedbusinesses(s0076) #health--otherdiseases&medicalconditions(i0383) #intellectualproperty(s0501) #lieutenantgovernor(s0096) #protectionofpersonalinformation(i0003) #research&development(s0135) #riceuniversity(u699w) #speakerofthehouse(s0306) #stateagencies #boards&commissions--newlyproposed(i0773) #statefinances--management&control(i0748) #texasa&muniversitysystem(u0079) #texasstateuniversitysystem(u0080) #texastechuniversitysystem(u0027) #treasurysafekeepingtrustcompany #texas(v0094) #universityofhoustonsystem(u0442) #universityofnorthtexassystem(u0050) #universityoftexassystem(u0045)

Legislative bill overview

SB 998 proposes establishing the Alzheimer's Prevention and Research Institute of Texas, a state entity dedicated to research, prevention, and treatment initiatives for Alzheimer's disease and related dementias. The bill, sponsored by Senator Judith Zaffirini, would create an institutional framework to coordinate research efforts and potentially secure funding for Alzheimer's-focused programs within Texas.

Why is this important

Alzheimer's disease affects approximately 400,000 Texans and represents a growing public health challenge as the population ages. Creating a dedicated institute could accelerate research into prevention and treatment while positioning Texas as a leader in dementia research, potentially attracting federal grants and private investment that benefit both patients and the state's economy.

Potential points of contention

Funding source and cost: The bill's passage through Finance Committee will likely scrutinize whether new state appropriations are required or if existing resources would be redirected, impacting other budget priorities during tight fiscal periods.

Governance and oversight structure: Details about the institute's board composition, administrative costs, and accountability mechanisms are not yet specified, raising questions about political influence versus scientific independence.

Research focus and implementation: Stakeholders may debate whether resources should prioritize basic research, clinical trials, prevention programs, or care infrastructure, given limited funding availability.